Antifibrotic Effects of 1,25(OH)₂D₃ on Nonalcoholic Steatohepatitis in Female Mice

Keyphrases

• Nonalcoholic Steatohepatitis 100%
• Female Mice 100%
• 1,25(OH)2D3 100%
• Antifibrotic 100%
• Choline-deficient 57%
• High-fat Diet 42%
• Liver Function 28%
• C57BL 14%
• Smad3 14%
• Treatment Effect 14%
• Serum Levels 14%
• Blood Samples 14%
• High Risk 14%
• Smad2 14%
• Fibrosis 14%
• Liver Fibrosis 14%
• Intraperitoneal Injection 14%
• Postmenopausal Women 14%
• Therapeutic Effect 14%
• Fibrosis Stage 14%
• Tissue Inhibitor of metalloproteinase-1 (TIMP-1) 14%
• Vitamin D Deficiency 14%
• Menopause 14%
• Steatosis 14%
• Postmenopause 14%
• Liver Tissue 14%
• Ovariectomy 14%
• OVX Mice 14%
• Functional Genes 14%
• Hepatic Function 14%
• High-fat Diet Mice 14%
• Lobular Inflammation 14%
• COL1A1 14%
• Fibrotic Markers 14%
• Liver Histological Changes 14%
• Serum Biochemical Indicators 14%
• Hepatic Genes 14%

Medicine and Dentistry

• Nonalcoholic Fatty Liver 100%
• Choline 57%
• High Fat Food 57%
• Liver Function 42%
• Fibrosis 28%
• Supplementation 28%
• Postmenopause 28%
• Liver Fibrosis 14%
• Intraperitoneal Drug Administration 14%
• Steatosis 14%
• Liver Tissue 14%
• Therapy Effect 14%
• Ovariectomy 14%
• Metalloprotease Inhibitor 14%
• Vitamin D Deficiency 14%
• Hypovitaminosis D 14%
• Injection 14%
• Inflammation 14%

Pharmacology, Toxicology and Pharmaceutical Science

• Nonalcoholic Fatty Liver 100%
• Choline 57%
• Fibrosis 28%
• Inflammation 14%
• Liver Fibrosis 14%
• Therapeutic Effect 14%
• Hypovitaminosis D 14%
• Intraperitoneal Injection 14%
• Vitamin D Deficiency 14%
• Steatosis 14%
• Postmenopause 14%
• Tissue Inhibitor of Metalloproteinase 14%